Eupraxia Pharmaceuticals Inc. (ADR)
General ticker "EPRX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $156.8M (TTM average)
Eupraxia Pharmaceuticals Inc. (ADR) follows the US Stock Market performance with the rate: 52.9%.
Estimated limits based on current volatility of 2.9%: low 7.93$, high 8.40$
Short-term EPRX quotes
Long-term EPRX plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | CA$0.00MM | CA$0.00MM | CA$0.00MM |
| Operating Expenses | CA$17.62MM | CA$27.85MM | CA$38.83MM |
| Operating Income | CA$-17.62MM | CA$-27.85MM | CA$-38.83MM |
| Non-Operating Income | CA$-1.37MM | CA$-1.08MM | CA$1.81MM |
| Interest Expense | CA$0.98MM | CA$1.17MM | CA$0.87MM |
| R&D Expense | CA$13.63MM | CA$20.36MM | CA$23.12MM |
| Income(Loss) | CA$-18.99MM | CA$-28.93MM | CA$-37.02MM |
| Taxes | CA$-0.00MM | CA$-0.04MM | CA$0.00MM |
| Profit(Loss)* | CA$-18.49MM | CA$-28.22MM | CA$-25.74MM |
| Stockholders Equity | CA$10.54MM | CA$2.22MM | CA$33.40MM |
| Assets | CA$25.89MM | CA$20.27MM | CA$34.94MM |
| Operating Cash Flow | CA$-14.40MM | CA$-20.75MM | CA$-29.99MM |
| Capital expenditure | CA$0.24MM | CA$0.07MM | CA$0.10MM |
| Investing Cash Flow | CA$9.83MM | CA$-0.07MM | CA$-0.08MM |
| Financing Cash Flow | CA$10.80MM | CA$21.08MM | CA$45.78MM |
| Earnings Per Share** | CA$-0.96 | CA$-1.17 | CA$-0.76 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.